Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Xiubao Ren

ResearcherPublications, citations & collaboration network

Xiubao Ren is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 449 works, 15,130 citations, an h-index of 62 and an i10-index of 195.

449
Works
15,130
Citations
62
h-index
195
i10-index

How has Xiubao Ren's publication output changed over time?

ScholarIQpublication output · 2008–2024

Output grew100% over the shown period — from 1 works in 2008 to 2 in 2024.

1
1
1
1
1
1
1
2
1
2
2008201020132014201520162018202020222024

What are the most-cited papers on Xiubao Ren?

ScholarIQmost cited works
Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis
Miranda Fong, Weiying Zhou, Liang Liu, Aileen Y. Alontaga, Manasa Chandra, Jonathan Ashby, Amy Chow, Sean Timothy Francis O’Connor, Shasha Li, Andrew R. Chin, George Somlo, Melanie R. Palomares, Zhuo Li, Jacob R. Tremblay, Akihiro Tsuyada, Guoqiang Sun, Michael A. Reid, Xiwei Wu, Piotr Swiderski, Xiubao Ren, Yanhong Shi, Mei Kong, Wenwan Zhong, Yuan Chen, Shizhen Emily Wang
S151741590. 20151,117 CitationsOPEN ACCESS
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
Howard H. Yang, Jianhua Huang, Xiubao Ren, Agnieszka E. Gorska, Anna Chytil, Mary Aakre, David P. Carbone, Lynn M. Matrisian, Ann Richmond, P. Charles Lin, Harold L. Moses
S25671836. 2008920 CitationsOPEN ACCESS
Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
Jinpu Yu, Weijiao Du, Yan Fang, Yue Wang, Hui Li, Shui Cao, Wenwen Yu, Chun Shen, Juntian Liu, Xiubao Ren
S38008053. 2013605 Citations
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
Caicun Zhou, Gongyan Chen, Yunchao Huang, Jianying Zhou, Lizhu Lin, Jifeng Feng, Zhehai Wang, Yongqian Shu, Jianhua Shi, Yi Hu, Qiming Wang, Ying Cheng, Fengying Wu, Jianhua Chen, Xiaoyan Lin, Yongsheng Wang, Jianan Huang, Jiuwei Cui, Lejie Cao, Yunpeng Liu, Yiping Zhang, Yueyin Pan, Jun Zhao, Liping Wang, Jianhua Chang, Qun Chen, Xiubao Ren, Wei Zhang, Yun Fan, Zhiyong He, Jian Fang, Kangsheng Gu, Xiaorong Dong, Tao Zhang, Wei Shi, Jianjun Zou
The Lancet Respiratory Medicine. 2020508 Citations
Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells
Wei Yan, Xiwei Wu, Weiying Zhou, Miranda Fong, Minghui Cao, Juan Liu, Xiaojing Liu, Chih-Hong Chen, Oluwole Fadare, Donald Pizzo, Jiawen Wu, Liang Liu, Xuxiang Liu, Andrew R. Chin, Xiubao Ren, Yuan Chen, Jason W. Locasale, Shizhen Emily Wang
S151741590. 2018485 CitationsOPEN ACCESS

Related on ScholarIQ

National Medical Products Administration
Institution
Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis
Paper
Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
Paper
Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
Paper
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
Paper
Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells
Paper
470M+ articles · free account